Showing results (241-250 of 303) with videos related to

Sort By:
Pageof 31
Clinical and Molecular Hepatology|April 16, 2024
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysisHarry Crane, Guy D Eslick, Cameron Gofton, et al.
Plos One|July 11, 2019
CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injuryChristine Yee, Nathan M Main, Alexandra Terry, et al.
Journal of Diabetes|October 29, 2014
Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional studyKathryn H Williams, Ana Júlia Vieira De Ribeiro, Emilia Prakoso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
Molecular & Cellular Proteomics : MCP|September 28, 2018
Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and ProteomicsHui Emma Zhang, Elizabeth J Hamson, Maria Magdalena Koczorowska, et al.
Cellular and Molecular Life Sciences : CMLS|July 22, 2022
Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7Jinbiao Chen, Yang Zhao, Fan Zhang, et al.
Hepatology Communications|January 6, 2025
Spatial mapping of the HCC landscape identifies unique intratumoral perivascular-immune neighborhoodsFelix Marsh-Wakefield, Cositha Santhakumar, Angela L Ferguson, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Drug and Alcohol Review|August 2, 2024
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Pageof 31